<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
ANIX
Anixa Biosciences
$
()


  • Fly Insider: Crocs, Best Buy among week's notable insider trades

    3/18/2024 - 15:06pm
  • Anixa Biosciences begins dosing in second cohort of ovarian cancer CAR-T trial

    2/12/2024 - 07:32am
  • Anixa Biosciences granted ovarian cancer vaccine technology patent in Japan

    1/23/2024 - 07:58am
  • Meet Anixa Biosciences: Fly exclusive interview with CEO Amit Kumar

    1/4/2024 - 14:07pm
  • Commercialization through large partner among Anixa goals, CEO tells The Fly

    1/4/2024 - 14:00pm
  • Anixa could begin human testing for ovarian cancer vaccine by 2025, CEO says

    1/4/2024 - 14:00pm
  • Anixa CEO says breast cancer vaccine data looking 'incredibly promising'

    1/4/2024 - 14:00pm
  • Anixa looking to change cancer landscape with preventive vaccines, CEO says

    1/4/2024 - 14:00pm
  • Anixa Biosciences' breast cancer vaccine shows positive Phase 1 results

    12/6/2023 - 18:07pm
  • Anixa Biosciences announces European patent on ovarian cancer vaccine technology

    11/27/2023 - 08:32am
  • Anixa Biosciences completes first patient cohort in ovarian cancer CAR-T trial

    10/13/2023 - 08:38am
  • Anixa Biosciences granted additional U.S. patent for ovarian cancer vaccine tech

    10/3/2023 - 08:32am
  • Anixa Biosciences announces treatment of third patient in CAR-T trial

    8/28/2023 - 08:34am
  • Anixa Biosciences announces enrollment for Keytruda treatment arm

    8/7/2023 - 08:33am
  • Anixa Biosciences announces Notice of Allowance of additional patent

    7/27/2023 - 08:33am
dynamic_feed Breaking News